Funding new technology for more accurate diagnosis and treatment planning for patients.
Together with generous donors, the QEII Foundation is raising $430,000 to bring Atlantic Canada’s first Cone Beam CT scanner to the QEII.
What donors will make possible
Increased diagnostic imaging access
Some of the smallest bones in the human body are in the head and neck. To diagnose and treat diseases in these areas, doctors need advanced imaging technology. Without it, patients face underdiagnosis or long wait times that impact their health.
The answer is a Cone Beam CT scanner. This advanced tool produces incredibly detailed 3D images of the head and neck, enabling more accurate diagnosis and treatment planning for certain cancers, soft tissue and bone injuries.
As part of the QEII Foundation’s $100 million We Are campaign, donors will help reduce wait times and increase access to care.
Right now, patients who could benefit from Cone Beam CT scans receive MRI or CT scans instead. Adding this technology will free up 2,500 MRI and CT scans annually, ensuring patients get the right imaging for their condition.
Adding more innovative diagnostic imaging technology will create system-wide efficiencies and create better patient access.
Your gift today will give more patients access to the critical diagnostic imaging scans they need for more accurate diagnosis and faster treatment.
Bringing the Cone Beam CT to the QEII will establish Canada’s first Head and Neck Radiology section within the QEII’s Department of Diagnostic Imaging. It will also lay the groundwork for Canada’s first medical fellowship in Head and Neck Radiology, bolstering recruitment to attract top specialists worldwide to the QEII.
The Cone Beam CT will be a guiding force for healthcare teams in the diagnosis and treatment of patients and help unlock new research and innovation opportunities that otherwise wouldn’t be possible.
Dr. Jens Heidenreich, sub-section head of head & neck, neuroradiology at the QEII, says the new Cone Beam CT scanner will help attract top medical talent to the QEII and create novel research opportunities that impact patient care.
